No abstract available
MeSH terms
-
Benzamides
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
-
Molecular Diagnostic Techniques
-
Neoplasm, Residual / diagnosis*
-
Piperazines / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Recurrence
-
Remission Induction
Substances
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate